Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

MR837

Copy Product Info
🥰Excellent
Catalog No. T8879Cas No. 1210906-48-1
Alias ZINC30303842, NSD2-PWWP1 antagonist 3f

MR837 (NSD2-PWWP1 antagonist 3f) is a NSD2-PWWP1 antagonist.

MR837

MR837

Copy Product Info
🥰Excellent
Purity: 99.85%
Catalog No. T8879Alias ZINC30303842, NSD2-PWWP1 antagonist 3fCas No. 1210906-48-1
MR837 (NSD2-PWWP1 antagonist 3f) is a NSD2-PWWP1 antagonist.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$34In StockIn Stock
5 mg$53In StockIn Stock
10 mg$88In StockIn Stock
25 mg$148In StockIn Stock
50 mg$269In StockIn Stock
100 mg$395In StockIn Stock
200 mg$557In StockIn Stock
1 mL x 10 mM (in DMSO)$64In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

MR837 AI Summary
MR837 has bioactivities related to both the NSD2 and NSD3 proteins. It shows notable binding affinity to the NSD2 PWWP1 domain with dissociation constants (Kd) of 7000.0 nM and 3400.0 nM under different conditions. Additionally, it can displace Halo-tagged Histone H3.3 from Nanoluc-tagged NSD2-PWWP1 in human U2OS cells with an IC50 value of 17300.0 nM. Moreover, it exhibits a dissociation constant (Kd) of 91.0 nM when binding to NSD3. The compound also shows binding affinity to the N-terminal His6/Sumo-tagged NSD2 PWWP1 domain (211 to 350 residues) with an IC50 value of 24670.0 nM, as assessed using the HTRF assay method with a specific substrate..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
MR837 (NSD2-PWWP1 antagonist 3f) is a NSD2-PWWP1 antagonist.
SynonymsZINC30303842, NSD2-PWWP1 antagonist 3f
Chemical Properties
Molecular Weight282.36
FormulaC16H14N2OS
Cas No.1210906-48-1
SmilesO=C(N(Cc1cccs1)C1CC1)c1ccc(cc1)C#N
Relative Density.1.29 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 11 mg/mL (38.96 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.08 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.5416 mL17.7079 mL35.4158 mL177.0789 mL
5 mM0.7083 mL3.5416 mL7.0832 mL35.4158 mL
10 mM0.3542 mL1.7708 mL3.5416 mL17.7079 mL
20 mM0.1771 mL0.8854 mL1.7708 mL8.8539 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy MR837 | purchase MR837 | MR837 cost | order MR837 | MR837 chemical structure | MR837 formula | MR837 molecular weight